Meanwhile, BCR-ABL1 increases glucose metabolism and activates mitochondrial electron transport chains specifically regulated by PI3K-AKT-mTOR in CML cells [104, 105]. Here, MTOR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.